4 ms·
Interesting. I wonder if this is revenge for DOT blocking the Allergan deal. Good for Pfizer for showing some cajones.
by leesalminen 10y ago
Interesting. I wonder if this is revenge for DOT blocking the Allergan deal.
Good for Pfizer for showing some cajones.
- amelius 10y ago> Good for Pfizer for showing some cajones. Well, you could also view this from the opposite angle: if they didn't block this, how good would it look on them? Also, I can't help but wonder what their stance would be if the "execution" market was much larger. Anyway, I still applaud this move of course, that is not the point.
- chillacy 10y agoI imagined drug commercials for execution drugs. Side effects include dizziness, headaches, vomiting, and on rare occasions, not-death.
- refurb 10y agoThis is just a continuation of Hospira's policy. Pfizer purchased Hospira a year or two back. If you think about it from a PR move, it's a low risk move.
- lukeschlather 10y agoThe Secretary of the Treasury is currently a Democrat. While I don't think he's taken a position on the death penalty, Democrats tend to be anti-capital punishment and this would be a pretty bizarre way to thumb your nose at a Democrat. Even Democrats who claim to be pro-death penalty would likely privately be happy about this.
- masklinn 10y agoAssuming the worst of people, that seems like a pretty good reason to do it: the democrats in office are happy because you're hindering death penalties, but they don't risk political backlash because they didn't order/do anything, Pfizer did.
- troisx 10y agoThis is the opposite of showing cajones. Manufacturers of these drugs have been sued because their drugs were used for executions. So this is a attempt to avoid liability.